ScripsAmerica Inc. (SCRCQ)

Overview

ScripsAmerica, Inc., founded in 2008 and headquartered in Clifton, New Jersey, embarked on developing and distributing non-sterile topical and transdermal pain creams. Over the years, the company broadened its scope to include pharmacy dispensing services tailored for individual doctors, in addition to offering billing and administrative support to independent pharmacies. Moreover, ScripsAmerica played a pivotal role in the pharmaceutical supply chain by distributing products to independent pharmacies and various medical providers. Nonetheless, the company faced financial difficulties, filing for Chapter 11 bankruptcy on September 7, 2016. Subsequently, its petition for reorganization under Chapter 11 was converted to Chapter 7 on February 8, 2017, marking the end of its operational activities.

Products and Services

• Non-sterile Topical and Transdermal Pain Creams
  

  ScripsAmerica developed a line of non-sterile pain management products, including topical and transdermal creams. These products were designed to provide patients with relief from various types of pain without the need for oral medications, targeting the discomfort directly at its source.

• Pharmacy Dispensing Services
  

  The company offered specialized dispensing services, catering specifically to the needs of individual healthcare providers. This service aimed to streamline the prescription process, ensuring that physicians could directly provide patients with necessary medications, thereby enhancing the efficiency and personalization of treatment.

• Billing and Administrative Services
  

  ScripsAmerica extended its services to aid independent pharmacies with billing and administrative tasks. This support was crucial in reducing the operational burden on pharmacies, allowing them to focus more on patient care and less on administrative complexities.

• Distribution of Pharmaceutical Products
  

  Understanding the needs of independent pharmacies and medical providers, ScripsAmerica also operated as a distributor of pharmaceutical products. This role was vital in ensuring that these entities had access to a wide range of medications, thereby enhancing their ability to cater to the diverse needs of their patients.